Capricor Therapeutics Inc.

NASDAQ: CAPR
Share price (3/25/25): $13.48
Market cap (3/25/25): $613 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Shelf registration

Prospectus supplement for primary offering

Shelf registration – amended

Prospectus supplement for primary offering

Ownership Filter

Dunbar George W Jr

Bergmann Anthony

Collier Earl M Jr

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Announces FDA Acceptance and Priority Review of Its Biologics License Application for Deramiocel to Treat Duchenne Muscular Dystrophy

Completes Submission of Biologics License Application to the U.S. FDA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Announces Pricing of Approximately $75 Million Public Offering of Common Stock

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC